Robert Ollinger

Summary

Affiliation: Innsbruck Medical University
Country: Austria

Publications

  1. doi request reprint Evolution of pancreas transplantation: long-term results and perspectives from a high-volume center
    Robert Ollinger
    Department of Visceral, Transplant and Thoracic Surgery, Medical University Innsbruck, Anichstrasse 35, Innsbruck, Tyrol, Austria
    Ann Surg 256:780-6; discussion 786-7. 2012
  2. pmc A multicentre, randomized clinical trial comparing the Veriset™ haemostatic patch with fibrin sealant for the management of bleeding during hepatic surgery
    Robert Ollinger
    Department of Visceral, Transplant and Thoracic Surgery, Medical University Innsbruck, Innsbruck, Austria
    HPB (Oxford) 15:548-58. 2013
  3. ncbi request reprint Bilirubin inhibits tumor cell growth via activation of ERK
    Robert Ollinger
    Department of General and Transplant Surgery, D Swarovski Research Lab, Innsbruck Medical University, Innsbruck, Austria
    Cell Cycle 6:3078-85. 2007
  4. ncbi request reprint Protein levels of heme oxygenase-1 during reperfusion in human kidney transplants with delayed graft function
    Robert Ollinger
    Department of General and Transplant Surgery, D Swarovski Research Lab, Medical University Innsbruck, Innsbruck, Austria
    Clin Transplant 22:418-23. 2008
  5. doi request reprint Blockade of p38 MAPK inhibits chronic allograft vasculopathy
    Robert Ollinger
    Department of General and Transplant Surgery, D Swarovski Research Lab, Medical University Innsbruck, Innsbruck, Austria
    Transplantation 85:293-7. 2008
  6. ncbi request reprint Therapeutic applications of bilirubin and biliverdin in transplantation
    Robert Ollinger
    Department of Surgery, Medical University Innsbruck, Innsbruck, Austria
    Antioxid Redox Signal 9:2175-85. 2007
  7. ncbi request reprint Bilirubin and biliverdin treatment of atherosclerotic diseases
    Robert Ollinger
    Department of Surgery, Innsbruck Medical University, Innsbruck, Austria
    Cell Cycle 6:39-43. 2007
  8. ncbi request reprint Tacrolimus monotherapy following alemtuzumab induction in combined kidney-pancreas transplantation: results of a prospective randomized trial
    Claudia Bösmüller
    Department of Visceral, Transplant and Thoracic Surgery, Center of Operative Medicine, Innsbruck Medical University, Anichstrasse 35, Innsbruck, Austria
    Ann Transplant 17:45-51. 2012
  9. doi request reprint Combined pancreas-kidney transplantation for patients with end-stage nephropathy caused by type-2 diabetes mellitus
    Christian Margreiter
    Department of Visceral, Transplant, and Thoracic Surgery, Innsbruck Medical University, Austria
    Transplantation 95:1030-6. 2013
  10. doi request reprint Tetrahydrobiopterin protects the kidney from ischemia-reperfusion injury
    Robert Sucher
    Department of Visceral, Transplant and Thoracic Surgery, Center of Operative Medicine, Innsbruck Medical University, Innsbruck, Austria
    Kidney Int 77:681-9. 2010

Collaborators

Detail Information

Publications28

  1. doi request reprint Evolution of pancreas transplantation: long-term results and perspectives from a high-volume center
    Robert Ollinger
    Department of Visceral, Transplant and Thoracic Surgery, Medical University Innsbruck, Anichstrasse 35, Innsbruck, Tyrol, Austria
    Ann Surg 256:780-6; discussion 786-7. 2012
    ..The aim was to examine factors influencing long-term patient and graft survival, surgical methods, and risk factors influencing organ performance after transplantation...
  2. pmc A multicentre, randomized clinical trial comparing the Veriset™ haemostatic patch with fibrin sealant for the management of bleeding during hepatic surgery
    Robert Ollinger
    Department of Visceral, Transplant and Thoracic Surgery, Medical University Innsbruck, Innsbruck, Austria
    HPB (Oxford) 15:548-58. 2013
    ..It is designed to achieve haemostasis quickly and adhere to tissues without fixation...
  3. ncbi request reprint Bilirubin inhibits tumor cell growth via activation of ERK
    Robert Ollinger
    Department of General and Transplant Surgery, D Swarovski Research Lab, Innsbruck Medical University, Innsbruck, Austria
    Cell Cycle 6:3078-85. 2007
    ..These effects were dependent on ERK 1/2. Our study demonstrates that bilirubin may play a role in the defense against cancer by interfering with pro-cancerogenic signaling pathways...
  4. ncbi request reprint Protein levels of heme oxygenase-1 during reperfusion in human kidney transplants with delayed graft function
    Robert Ollinger
    Department of General and Transplant Surgery, D Swarovski Research Lab, Medical University Innsbruck, Innsbruck, Austria
    Clin Transplant 22:418-23. 2008
    ..The aim of our study was to analyze whether HO-1 protein levels in human kidney transplants during IRI correlate with the incidence of DGF...
  5. doi request reprint Blockade of p38 MAPK inhibits chronic allograft vasculopathy
    Robert Ollinger
    Department of General and Transplant Surgery, D Swarovski Research Lab, Medical University Innsbruck, Innsbruck, Austria
    Transplantation 85:293-7. 2008
    ....
  6. ncbi request reprint Therapeutic applications of bilirubin and biliverdin in transplantation
    Robert Ollinger
    Department of Surgery, Medical University Innsbruck, Innsbruck, Austria
    Antioxid Redox Signal 9:2175-85. 2007
    ..This review attempts to summarize these protective roles as well as the molecular mechanisms by which biliverdin/bilirubin benefit IRI and solid-organ transplantation, including chronic rejection, and islet transplantation...
  7. ncbi request reprint Bilirubin and biliverdin treatment of atherosclerotic diseases
    Robert Ollinger
    Department of Surgery, Innsbruck Medical University, Innsbruck, Austria
    Cell Cycle 6:39-43. 2007
    ....
  8. ncbi request reprint Tacrolimus monotherapy following alemtuzumab induction in combined kidney-pancreas transplantation: results of a prospective randomized trial
    Claudia Bösmüller
    Department of Visceral, Transplant and Thoracic Surgery, Center of Operative Medicine, Innsbruck Medical University, Anichstrasse 35, Innsbruck, Austria
    Ann Transplant 17:45-51. 2012
    ..We investigated the safety and efficacy of Campath induction and tacrolimus (TAC) maintenance therapy compared to ATG induction with TAC +MMF + steroids in de novo kidney-pancreas transplanted patients...
  9. doi request reprint Combined pancreas-kidney transplantation for patients with end-stage nephropathy caused by type-2 diabetes mellitus
    Christian Margreiter
    Department of Visceral, Transplant, and Thoracic Surgery, Innsbruck Medical University, Austria
    Transplantation 95:1030-6. 2013
    ....
  10. doi request reprint Tetrahydrobiopterin protects the kidney from ischemia-reperfusion injury
    Robert Sucher
    Department of Visceral, Transplant and Thoracic Surgery, Center of Operative Medicine, Innsbruck Medical University, Innsbruck, Austria
    Kidney Int 77:681-9. 2010
    ..We suggest that BH4 significantly protects against acute renal failure following ischemia reperfusion. Whether BH4 has a therapeutic potential will require more direct testing in humans...
  11. doi request reprint Recipient and donor body mass index as important risk factors for delayed kidney graft function
    Annemarie Weissenbacher
    Department of Visceral, Transplant and Thoracic Surgery, Center of Operative Medicine, Innsbruck Medical University, Innsbruck, Austria
    Transplantation 93:524-9. 2012
    ..Obesity is increasingly impacting the overall health status and the global costs for health care. The increase in body mass index (BMI) is also observed in kidney allograft recipients and deceased organ donors...
  12. doi request reprint Single-center experience with third and fourth kidney transplants
    Katrin Kienzl-Wagner
    Center for Operative Medicine, Department of Visceral, Transplant and Thoracic Surgery, Innsbruck Medical University, Innsbruck, Austria
    Transpl Int 24:780-6. 2011
    ..Graft losses in this sensitized population are mainly because of rejection. Profound immunosuppression may lead to major infectious problems...
  13. doi request reprint Nighttime procedures are not associated with adverse outcomes in kidney transplantation
    Katrin Kienzl-Wagner
    Department of Visceral, Transplant and Thoracic Surgery, Center of Operative Medicine, Innsbruck Medical University, Innsbruck, Austria
    Transpl Int 26:879-85. 2013
    ..02). Nighttime kidney transplants are neither associated with a higher surgical complication rate nor worse 5-year outcomes than daytime procedures, thus are justified to keep CIT short...
  14. doi request reprint Enteroscopic biopsies in the management of pancreas transplants: a proof of concept study for a novel monitoring tool
    Christian Margreiter
    Department of Visceral, Transplant and Thoracic Surgery, Innsbruck Medical University, Innsbruck, Austria
    Transplantation 93:207-13. 2012
    ..On the other hand, correct diagnosis of rejection is essential but may be difficult in cases of enteric drainage, particularly in patients with a pancreas transplant alone or a pancreas after kidney transplant...
  15. pmc IDO and regulatory T cell support are critical for cytotoxic T lymphocyte-associated Ag-4 Ig-mediated long-term solid organ allograft survival
    Robert Sucher
    Department of Visceral, Transplant and Thoracic Surgery, Innsbruck Medical University, A 6020 Innsbruck, Austria
    J Immunol 188:37-46. 2012
    ..These results have important implications for the clinical development of this costimulatory blocker...
  16. ncbi request reprint Bilirubin rinse of the graft ameliorates ischemia reperfusion injury in heart transplantation
    Florian Bosch
    Department of Visceral, Transplant and Thoracic Surgery, Medical University Innsbruck, Innsbruck, Austria Department of Surgery, Ludwig Maximilians University Munich, Munich, Germany
    Transpl Int 27:504-13. 2014
    ..05) and significantly suppressed apoptosis. Ex vivo administration of bilirubin to heart grafts prior reperfusion ameliorates IRI and provides a simple and effective tool to ameliorate outcome in heart transplantation. ..
  17. doi request reprint Hepatic artery reconstruction with inferior mesenteric vein graft in pediatric living donor liver transplantation
    Christian Margreiter
    Department of General and Transplant Surgery, Innsbruck Medical University, Innsbruck, Austria
    Pediatr Transplant 12:324-8. 2008
    ..From this experience we can recommend the IMV as an alternative to the saphenous vein for an interposition graft...
  18. doi request reprint Role of heme oxygenase-1 in transplantation
    Robert Ollinger
    Department of Visceral, Transplant and Thoracic Surgery, Medical University Innsbruck, Innsbruck, Austria
    Transpl Int 23:1071-81. 2010
    ....
  19. ncbi request reprint The 'Blind Innsbruck Ostomy', a cutaneous enterostomy for long-term histologic surveillance after small bowel transplantation
    Alfred Konigsrainer
    Department of General and Transplant Surgery, Innsbruck Medical University Hospital, Innsbruck, Austria
    Transpl Int 20:867-74. 2007
    ..A long-term cutaneous enterostomy, even if disconnected from the intestinal continuity, enables simple long-term monitoring of small bowel allografts...
  20. doi request reprint Intracellular signaling pathways control mitochondrial events associated with the development of ischemia/ reperfusion-associated damage
    Robert Sucher
    Daniel Swarovski Research Laboratory DSL, Department of Visceral, Transplant and Thoracic Surgery, Center of Operative Medicine, Innsbruck Medical University IMU, Innsbruck, Austria
    Transpl Int 22:922-30. 2009
    ..Inhibiting p38 kinase most efficiently prevented ROS production, Ca2+ overload and cell death, suggesting that targeting this signaling molecule may provide a possible strategy to limit the effects of IR...
  21. ncbi request reprint Gemcitabine with cyclosporine or with tacrolimus exerts a synergistic effect and induces tolerance in the rat
    Hans Christian Jeske
    Department of Transplant Surgery, D Swarovski Research Laboratory, Innsbruck University Hospital, Innsbruck, Austria
    Transplantation 76:1046-52. 2003
    ..This study investigated the effect of the antineoplastic agent gemcitabine (dFdC) in combination with cyclosporine (CsA) or with FK506 on acute heart allograft rejection in a rat model...
  22. ncbi request reprint Markers of cellular senescence in zero hour biopsies predict outcome in renal transplantation
    Christian Koppelstaetter
    Division of Nephrology, Department of Internal Medicine, Medical University Innsbruck, Innsbruck, Austria
    Aging Cell 7:491-7. 2008
    ..We conclude that the molecular aging marker CDKN2A in combination with chronological donor age predict renal allograft function after 1 year significantly better than chronological donor age alone...
  23. ncbi request reprint Bilirubin: a natural inhibitor of vascular smooth muscle cell proliferation
    Robert Ollinger
    Department of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA
    Circulation 112:1030-9. 2005
    ....
  24. ncbi request reprint Donor treatment with carbon monoxide can yield islet allograft survival and tolerance
    Hongjun Wang
    Department of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, 99 Brookline Ave, RN 361, Boston, MA 02215, USA
    Diabetes 54:1400-6. 2005
    ..Our present findings show that induction of HO-1 in, or administration of CO to, only the donor, islets, or the recipient or combinations of such treatments improve allogeneic islet survival...
  25. ncbi request reprint Biliverdin, a natural product of heme catabolism, induces tolerance to cardiac allografts
    Kenichiro Yamashita
    Department of Surgery, Immunobiology Research Center, Beth Israel Deaconess Medical Center, Harvard Medical School, 99 Brookline Ave, Boston, MA 02215, USA
    FASEB J 18:765-7. 2004
    ..These findings support the potential use of biliverdin, a natural product, in transplantation and other T cell mediated immune disorders...
  26. ncbi request reprint Heme oxygenase-1 is essential for and promotes tolerance to transplanted organs
    Kenichiro Yamashita
    Immunobiology Research Center, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215, USA
    FASEB J 20:776-8. 2006
    ....
  27. ncbi request reprint Biliverdin administration protects against endotoxin-induced acute lung injury in rats
    Judit K Sarady-Andrews
    Harvard Medical School, Beth Israel Deaconess Medical Center, 99 Brookline Avenue, Ste 370G, Boston, MA 02215, USA
    Am J Physiol Lung Cell Mol Physiol 289:L1131-7. 2005
    ..In conclusion, these data demonstrate that BV can modulate the inflammatory response and suppress pathophysiological changes in the lung and may therefore have therapeutic application in inflammatory disease states of the lung...
  28. ncbi request reprint Heme oxygenase-1 modulates the allo-immune response by promoting activation-induced cell death of T cells
    James McDaid
    Immunobiology Research Center, Department of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA
    FASEB J 19:458-60. 2005
    ....